Mizolastine in primary acquired cold urticaria

Journal of the American Academy of Dermatology

Volumn 48, Issue 4, 2003, Pages 578-583

  Dubertret, Louis ^b   Pecquet, Catherine ^b   Murrieta Aguttes, Margarita ^a   Leynadier, Francisque ^b  

^a SANOFI   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ICE; MIZOLASTINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COLD EXPOSURE; COLD URTICARIA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; MALE; MULTICENTER STUDY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROVOCATION TEST; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SIDE EFFECT; STATISTICAL SIGNIFICANCE; THERMAL STIMULATION; TREATMENT OUTCOME;

EID: 0037380464     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1067/mjd.2003.144     Document Type: Article

References (36)

1. Visitsunthorn N, Tuchinda M, Vichyanond H, Cold urticaria in Thai children: comparison between cyproheptadine and ketotifen in the treatment. Asian Pac J Allergy Immunol 1995;13:29-35.
2. Jorizzo JL, Smith EB. The physical urticarias: an update and review. Arch Dermatol 1982;118:194-201.
3. Wanderer AA. Cold urticaria syndromes: historical background, diagnosis classification, clinical and laboratory characteristics, pathogenesis and management. J Allergy Clin Immunol 1990;85:965-81.
4. Wanderer AA, Grandel KE, Wasserman SI, Farr RS. Clinical characteristics of cold-induced systemic reactions in acquired cold-urticaria syndromes: recommendations for prevention of this complication and proposal for a diagnostic classification of cold urticaria. J Allergy Clin Immunol 1986;78:416-23.
5. Wanderer AA. The spectrum of cold urticaria. Immunol Allergy Clin North Am 1995;15:701-23.
6. Neittaanmäki H. Cold urticaria: clinical findings in 220 patients. J Am Acad Dermatol 1985;13:636-44.
7. Koeppel MC, Bertrand S, Abitan R, Signoret R, Sayag J. Cold urticaria: clinical findings in 104 patients. Ann Dermatol Venereol 1996;123:627-32.
8. Ormerod AD, Reid TMS, Milford-Ward A. Familial cold urticaria: investigation of a family and response to stanolozol. Arch Dermatol 1993;129:343-6.
9. Visitsuntorn N, Tuchinda M, Arunyanark N, Kerdsomnuk S. Ice-cube test in children with cold urticaria. Asian Pac J Allergy Immunol 1992;10:111-5.
10. Kaplan AP, Gray L, Shaff RE, Horakova Z, Beaven MA. In vivo studies of mediator release in cold urticaria and cholinergic urticaria. J Allergy Clin Immunol 1975;55:394-402.
11. Grandel KE, Farr RS, Wanderer AA, Eisenstein TC, Wasserman SI. Association of platelet-activating factor with primary cold urticaria. N Engl J Med 1985;313:405-9.
12. Kaplan AP. Unusual cold-induced disorders: cold-dependent dermatographism and systemic cold urticaria. J Allergy Clin Immunol 1984;73:453-6.
13. Neittaanmäki H, Fräki JE. Combination of localized heat urticaria and cold urticaria: release of histamine in suction blisters and successful treatment of heat urticaria with doxepin. Clin Exp Dermatol 1988;13:87-91.
14. Ormerod AD, Kobza-Black A, Milford-Ward A, Greaves MW. Combined cold urticaria and cholinergic urticaria: clinical characterization and laboratory findings. Br J Dermatol 1988;118:621-7.
15. Kivity S, Schwartz Y, Wolf R, Topilsky M. Systemic cold-induced urticaria: clinical and laboratory characterization. J Allergy Clin Immunol 1990;85:52-4.
16. Hermes B, Prochazka, Haas N, Jurgovsky K, Sticherling M, Henz BM. Upregulation of TNF-α and IL-3 expression in lesional and uninvolved skin in different types of urticaria. J Allergy Clin Immunol 1999;103:307-14.
17. Michel L, Murrieta-Aguttes M, Jean-Louis FL, Levy D, Dubertret L. Humoral and cellular responses to histamine and pollen allergen in a skin chamber model: effect of mizolastine. Ann Allergy Asthma Immunol 2000;85:64-9.
18. Wanderer AA, Ellis EF. Treatment of cold urticaria with cyproheptadine. J Allergy Clin Immunol 1971;48:366-71.
19. Wanderer AA, St-Pierre JP, Ellis EF. Primary acquired cold urticaria: double-blind comparative study of treatment with cyproheptadine, chlorpheniramine and placebo. Arch Dermatol 1977;113:1375-7.
20. Sigler RW, Evan R III, Horakova Z, Ottensen E, Kaplan AP. The role of cyproheptadine in the treatment of cold urticaria. J Allergy Clin Immunol 1980;65:309-12.
21. Neittaanmäki H, Myöhänen T, Fräki JE. Comparison of cinnarizine, cyproheptadine, doxepin and hydroxyzine in the treatment of idiopathic cold urticaria: usefulness of doxepin. J Am Acad Dermatol 1984;11:483-9.
22. St-Pierre JP, Kobric M, Rackham A. Effect of ketotifen treatment on cold-induced urticaria. Ann Allergy 1985;55:840-3.
23. Neittaanmäki H, Fräki JE, Gibson JR. Comparison of the new antihistamine acrivastine (BW 825C) versus cyproheptadine in the treatment of idiopathic cold urticaria. Dermatologica 1988;177:98-103.
24. Juhlin L, de Vos C, Rihoux JP. Inhibiting effect of cetirizine on histamine-induced and 48/80-induced wheals and flares, experimental dermographism and cold-induced urticaria. J Allergy Clin Immunol 1987;80:599-602.
25. Villas Martinez F, Contreras FJ, Lopez Cazana JM, Lopez Serrano MC, Martinez Alzamora F. A comparison of new non-sedating and classical antihistamines in the treatment of primary acquired cold urticaria. J Invest Allergol Clin Immunol 1992;2:258-62.
26. 1 receptors in the rodent. Arzneimittelforschung Drug Res 1995;45:551-8.
27. Vargaftig BB. Mechanisms of experimental bronchopulmonary hyperresponsiveness as related to eosinophils. In: Langer SZ, Church MK, Vargaftig BB, Nicodia S, editors. New developments in the therapy of allergic disorders and asthma. Vol. 6. Basel: Karger; 1993. p. 27-32.
28. 1 receptor antagonist mizolastine in the rodent. Arzneimittelforschung Drug Res 1995;45:559-68.
29. Sudo K, Nagai K, Yamada N. Inhibitory effect of mizolastine on 5-lipoxygenase. Jpn Pharmacol Ther 1998;26:155-7.
30. Pichat P, Angel I, Arbilla S. Antiinflammatory properties of mizolastine after oral administration on arachidonic acid cutaneous reaction in the rat. Arzneimittelforschung Drug Res 1998;48:173-8.
31. 1-receptor antagonists. Clin Pharmacokinet 1999;36:329-52.
32. Bousquet J, Chanal I, Murrieta M, Stalla-Bourdillon A. Lack of subsensitivity to mizolastine over 8-week treatment. Allergy 1996;51:251-6.
33. Brostoff J, Fitzharris P, Dunmore C, Theron M, Blondin P. Efficacy of mizolastine, a new antihistamine, compared with placebo in the treatment of chronic idiopathic urticaria. Allergy 1996;51:320-5.
34. Dubertret L, Murrieta-Aguttes M, Tonet J, and the Milor Study Group. Efficacy and safety of mizolastine 10 mg in a placebo-controlled comparison with loratadine in chronic idiopathic urticaria: results of the milor study. J Eur Acad Dermatol Venereol 1999;12:16-24.
35. Lorette G, Pereira RS, Leynadier F, Murrieta-Aguttes M. One year treatment of chronic urticaria with mizolastine: efficacy and safety. J Eur Acad Dermatol Venereol 2000;14:83-90.
36. 1-receptor antagonist: results of a pool of 30 clinical phase II-III, double-blind studies [abstract]. Allergy 2000;55 (Suppl 63):247.